Across the spectrum of weight loss approaches, RDNs play a pivotal role in weight management
The authors attribute this shift to an imbalance between endothelium-derived relaxing factors (EDRFs)nitric oxide, prostacyclin, endothelium-derived hyperpolarizing factors, and natriuretic peptidesand endothelium-derived contracting factors (EDCFs), including endothelin-1, thromboxane A2, reactive oxygen species, and Rho-kinase signaling
Wegovy, or semaglutide 2.4, is the only weight-loss medicine approved by the US Food and Drug Administration (FDA) for weight management
Singh A, Sohal A, Batta A
Users should consult a healthcare professional before starting semaglutide and discuss potential drug interactions or allergies they might have so that the best decisions are made when it comes to their health